Treatment of recurrent ALL
Most adults with ALL relapse and require rescue treatment; rescue treatment usually has a poor outcome (40-50% rate of complete remission). The design of this treatment will depend on:
- previous treatments
- duration of first remission
- overall health of the patient
- organ function
The most widely used drug combinations to treat recurrent disease are:
- vincristine, anthracycline, and steroids
- methotrexate and L-asparaginase
- combination of high-dose cytarabine
All of the above are combined with the following regimens:
- HyperCVAD WITH L-asparaginase (cyclophosphamide, vincristine, doxorubicin, and dexamethasone)
- FLAG including cytarabine at high doses, fludarabine, and anthracycline
- MOAD (methotrexate, dexamethasone, vincristine, and L-asparaginase)
- Induction treatment is repeated if remission has lasted for more than 2 years.